Restless Legs Syndrome: A Review.

不宁腿综合征 医学 物理疗法 物理医学与康复 睡眠(系统调用) 睡眠质量 生活质量(医疗保健) 缺铁 补铁 刺痛
作者
John Weyl Winkelman,Benjamin Wipper
出处
期刊:PubMed [National Institutes of Health]
卷期号:335 (8): 703-714 被引量:30
标识
DOI:10.1001/jama.2025.23247
摘要

Importance: Restless legs syndrome (RLS) is a sleep-related movement disorder that affects approximately 3% of US adults to a clinically significant extent and can cause substantial sleep disturbance. Observations: Restless legs syndrome is characterized by an overwhelming urge to move the limbs, typically the legs, often accompanied by unpleasant limb sensations (eg, achiness, tingling). Symptoms, provoked by immobility, are relieved while moving and are typically present or most severe in the evening or at night. Restless legs syndrome symptoms may lead to difficulty falling asleep, staying asleep, or returning to sleep. According to population-based studies, approximately 8% of US adults experience RLS symptoms of any frequency annually and 3% experience moderately or severely distressing symptoms at least twice weekly. Patients with RLS have impaired quality of life and elevated rates of cardiovascular disease (29.6% with coronary artery disease, stroke, or heart failure), depression (30.4%), and suicidal ideation or self-harm (0.35 cases/1000 person-years). Restless legs syndrome is common among patients with multiple sclerosis (27.5%), end-stage kidney disease (24%), and iron deficiency anemia (23.9%); during pregnancy and especially in the third trimester (22%); with peripheral neuropathy (eg, diabetic, idiopathic; 21.5%); and with Parkinson disease (20%). Other risk factors include family history of RLS, northern European descent, female sex (2:1 vs male sex), and older age (RLS prevalence of 10% in adults ≥65 years). Restless legs syndrome is diagnosed based on clinical history; polysomnography is not recommended for diagnosis. Iron supplementation with ferrous sulfate (325-650 mg daily or every other day) or intravenous iron (1000 mg) should be initiated for serum ferritin level less than or equal to 100 ng/mL or transferrin saturation less than 20%. If possible, medications associated with RLS, including serotonergic antidepressants, dopamine antagonists, and centrally acting H1 antihistamines (eg, diphenhydramine), should be discontinued. Gabapentinoids (eg, gabapentin, gabapentin enacarbil, pregabalin) are first-line pharmacologic therapy. In randomized clinical trials, approximately 70% of patients treated with gabapentinoids had much or very much improved RLS symptoms vs approximately 40% with placebo (P < .001). Dopamine agonists (eg, ropinirole, pramipexole, rotigotine) are no longer recommended as first-line medications due to the risk of augmentation, an iatrogenic worsening of RLS symptoms, which has an annual incidence of 7% to 10% with these medications. Patients who do not improve with first-line treatment or have augmented RLS often benefit from low-dose opioids (eg, methadone 5-10 mg daily). Conclusions and Relevance: Restless legs syndrome affects approximately 3% of adults and can have negative effects on sleep and quality of life. Initial management includes cessation of exacerbating medications, as well as iron supplementation for patients with low-normal iron indices. If medication therapy is indicated, gabapentinoids are first-line treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Edenn完成签到,获得积分10
刚刚
石心粥发布了新的文献求助10
1秒前
1秒前
徐枘发布了新的文献求助10
1秒前
科研通AI65的应助被平常迎天采纳,获得30
2秒前
2秒前
2秒前
苗条梨愁发布了新的文献求助10
3秒前
3秒前
天天快乐的应助被能不学习吗采纳,获得10
3秒前
4秒前
甜甜的饼干完成签到 ,获得积分10
4秒前
5秒前
姚琛发布了新的文献求助10
6秒前
鹤轩发布了新的文献求助10
6秒前
可爱的函函的应助被XZM采纳,获得10
7秒前
DRX发布了新的文献求助10
7秒前
7秒前
xc发布了新的文献求助10
7秒前
黑米粥发布了新的文献求助200
7秒前
ku发布了新的文献求助10
7秒前
张宇完成签到,获得积分10
7秒前
lmn发布了新的文献求助10
7秒前
molihuakai的应助被郭姗姗采纳,获得10
8秒前
8秒前
肖帅帅完成签到,获得积分10
8秒前
昔年发布了新的文献求助10
8秒前
谢兰完成签到,获得积分10
9秒前
9秒前
kdby完成签到 ,获得积分10
9秒前
sure发布了新的文献求助10
9秒前
清辉影的应助被ggk采纳,获得150
9秒前
10秒前
温暖的炒饭的应助被Rming采纳,获得20
10秒前
11秒前
huxinyu发布了新的文献求助10
11秒前
gbh的应助被泡泡采纳,获得10
12秒前
伶俐的严青的应助被hxxx123采纳,获得30
12秒前
FashionBoy的应助被徐枘采纳,获得30
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611